These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33676020)

  • 1. Decision curve analysis to evaluate the clinical benefit of prediction models.
    Vickers AJ; Holland F
    Spine J; 2021 Oct; 21(10):1643-1648. PubMed ID: 33676020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the weighted area under the net benefit curve for decision curve analysis.
    Talluri R; Shete S
    BMC Med Inform Decis Mak; 2016 Jul; 16():94. PubMed ID: 27431531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calibration of risk prediction models: impact on decision-analytic performance.
    Van Calster B; Vickers AJ
    Med Decis Making; 2015 Feb; 35(2):162-9. PubMed ID: 25155798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROC curves for clinical prediction models part 1. ROC plots showed no added value above the AUC when evaluating the performance of clinical prediction models.
    Verbakel JY; Steyerberg EW; Uno H; De Cock B; Wynants L; Collins GS; Van Calster B
    J Clin Epidemiol; 2020 Oct; 126():207-216. PubMed ID: 32712176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node-positive prostate cancer patients: External validation on a multi-institutional database.
    Bianchi L; Schiavina R; Borghesi M; Bianchi FM; Briganti A; Carini M; Terrone C; Mottrie A; Gacci M; Gontero P; Imbimbo C; Marchioro G; Milanese G; Mirone V; Montorsi F; Morgia G; Novara G; Porreca A; Volpe A; Brunocilla E
    Int J Urol; 2018 Jun; 25(6):574-581. PubMed ID: 29633372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies.
    Rousson V; Zumbrunn T
    BMC Med Inform Decis Mak; 2011 Jun; 11():45. PubMed ID: 21696604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the prostate health index in a predictive model of prostate cancer.
    Sanchís-Bonet A; Barrionuevo-González M; Bajo-Chueca AM; Pulido-Fonseca L; Ortega-Polledo LE; Tamayo-Ruiz JC; Sánchez-Chapado M
    Actas Urol Esp (Engl Ed); 2018; 42(1):25-32. PubMed ID: 28811062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-Based ROC Curve: Examining the Effect of Case Mix and Model Calibration on the ROC Plot.
    Sadatsafavi M; Saha-Chaudhuri P; Petkau J
    Med Decis Making; 2022 May; 42(4):487-499. PubMed ID: 34657518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding decision curve analysis in clinical prediction model research.
    Zhao L; Leng Y; Hu Y; Xiao J; Li Q; Liu C; Mao Y
    Postgrad Med J; 2024 Jun; 100(1185):512-515. PubMed ID: 38453146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach for interpretability and reliability in clinical risk prediction: Acute coronary syndrome scenario.
    Valente F; Henriques J; Paredes S; Rocha T; de Carvalho P; Morais J
    Artif Intell Med; 2021 Jul; 117():102113. PubMed ID: 34127242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does [-2]Pro-Prostate Specific Antigen Meet the Criteria to Justify Its Inclusion in the Clinical Decision-Making Process?
    Sanchis-Bonet A; Barrionuevo-González M; Bajo-Chueca A; Morales-Palacios N; Sanchez-Chapado M
    Urol Int; 2018; 100(2):146-154. PubMed ID: 29346783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency department triage prediction of clinical outcomes using machine learning models.
    Raita Y; Goto T; Faridi MK; Brown DFM; Camargo CA; Hasegawa K
    Crit Care; 2019 Feb; 23(1):64. PubMed ID: 30795786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating metastatic disease: Which survival model is best suited for the clinic?
    Forsberg JA; Sjoberg D; Chen QR; Vickers A; Healey JH
    Clin Orthop Relat Res; 2013 Mar; 471(3):843-50. PubMed ID: 22983682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing Decision-Analysis Performances of Risk Prediction Models Using ADAPT Curves.
    Lee WC; Wu YC
    Medicine (Baltimore); 2016 Jan; 95(2):e2477. PubMed ID: 26765451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is My Clinical Prediction Model Clinically Useful? A Primer on Decision Curve Analysis.
    Mijderwijk HJ; Nieboer D
    Acta Neurochir Suppl; 2022; 134():115-118. PubMed ID: 34862535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram Prediction for the Risk of Diabetic Foot in Patients With Type 2 Diabetes Mellitus.
    Wang J; Xue T; Li H; Guo S
    Front Endocrinol (Lausanne); 2022; 13():890057. PubMed ID: 35909507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
    Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
    Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework.
    Vickers AJ; Cronin AM
    Semin Oncol; 2010 Feb; 37(1):31-8. PubMed ID: 20172362
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.